Université Clermont Auvergne

Valbiotis

Cnrs

Universite De La Rochelle

La Rochelle Université

Vivien Chavanelle

Pascal Sirvent

Sebastien Peltier

Thierry Maugard

Florian Le Joubioux

Sébastien Peltier

A composition comprising at least a mixture of molecules extracted fromandThis composition is in particular useful as a nutritional product or health product to prevent and/or combat fat and/or carbohydrate metabolism disorders in Humans or animals.

Composition comprising a mixture of molecules extracted from Chrysanthellum indicum, Cynara scolymus and Lycium barbarum and use to act on carbohydrate and/or fat metabolism

The invention relates to an active pharmaceutical ingredient consisting exclusively of the combination of (1S,3R,4R,5R)-3-{[(2E)-3-(3,4-)dihydroxyphenyl)-2-propenoyl]oxy}-1,4,5-trihydroxycyclohexanecarboxylic acid and of methyl (2S,3E,4S)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-(&#x3b2;-D-glucopyranosyloxy)-3,4-dihydro-2H-pyran-5-carboxylate for use as a drug or veterinary product, particularly in the prevention and/or treatment of pathological disorders of carbohydrate and/or lipid metabolism.

Pharmaceutical active ingredient and use thereof, in particular for the prevention and treatment of metabolic disorders in humans and animals

A composition comprising at least a mixture of molecules extracted fromand. This composition is in particular useful as a nutritional product or health product to prevent and/or combat fat and/or carbohydrate metabolism disorders in Humans or animals.

Composition comprising a mixture of molecules extracted from,andand use to act on carbohydrate and/or fat metabolism

Growing community of inventors

Clermont-Ferrand, France

Vivien Chavanelle